This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
7 Sep 2020

Inhalation formulation services with premier particle engineering platform

Lonza Pharma & Biotech provides integrated DPI (dry powder inhaler) development services to advance molecules, drawing on 25 years of experience in particle engineering, formulation design, and encapsulation techniques.
Our premier particle engineering technologies services, utilizing both jet milling and spray drying, are tailored to your molecule, target product profile and delivery device. Dedicated DPI formulation, analytical and manufacturing teams ensure that development timelines are met while minimizing program risk and complexity.

Mentioned Companies
Lonza
View company profile